Operating Lease, Right-of-Use Asset in USD of AVADEL PHARMACEUTICALS PLC from Q4 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
AVADEL PHARMACEUTICALS PLC quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2017 to Q3 2025.
  • AVADEL PHARMACEUTICALS PLC Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $2.54M, a 31.8% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

AVADEL PHARMACEUTICALS PLC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $2.54M +$614K +31.8% 30 Sep 2025 10-Q 04 Nov 2025
Q2 2025 $2.72M +$567K +26.3% 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $2.9M +$522K +22% 31 Mar 2025 10-Q 07 May 2025
Q4 2024 $1.7M -$889K -34.3% 31 Dec 2024 10-Q 04 Nov 2025
Q3 2024 $1.93M -$874K -31.2% 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 $2.15M +$919K +74.4% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $2.37M +$899K +60.9% 31 Mar 2024 10-Q 08 May 2024
Q4 2023 $2.59M +$878K +51.3% 31 Dec 2023 10-K 03 Mar 2025
Q3 2023 $2.8M +$857K +44% 30 Sep 2023 10-Q 08 Nov 2023
Q2 2023 $1.24M -$945K -43.3% 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 $1.48M -$935K -38.8% 31 Mar 2023 10-Q 04 May 2023
Q4 2022 $1.71M -$939K -35.4% 31 Dec 2022 10-K 29 Feb 2024
Q3 2022 $1.95M -$123K -5.94% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 $2.18M -$69K -3.07% 30 Jun 2022 10-Q 09 Aug 2022
Q1 2022 $2.41M -$17K -0.7% 31 Mar 2022 10-Q 09 May 2022
Q4 2021 $2.65M +$48K +1.84% 31 Dec 2021 10-K 29 Mar 2023
Q3 2021 $2.07M -$796K -27.8% 30 Sep 2021 10-Q 08 Nov 2021
Q2 2021 $2.25M -$868K -27.8% 30 Jun 2021 10-Q 09 Aug 2021
Q1 2021 $2.43M -$938K -27.9% 31 Mar 2021 10-Q 10 May 2021
Q4 2020 $2.6M -$1.01M -27.9% 31 Dec 2020 10-K 16 Mar 2022
Q3 2020 $2.87M -$1.52M -34.6% 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 $3.12M -$2.34M -42.8% 30 Jun 2020 10-Q 10 Aug 2020
Q1 2020 $3.37M -$2.44M -42% 31 Mar 2020 10-Q 11 May 2020
Q4 2019 $3.61M +$3.61M 31 Dec 2019 10-K 09 Mar 2021
Q3 2019 $4.39M -$1.58M -26.4% 30 Sep 2019 10-Q 12 Nov 2019
Q2 2019 $5.45M +$578K +11.9% 30 Jun 2019 10-Q 09 Aug 2019
Q1 2019 $5.8M 31 Mar 2019 10-Q 08 May 2019
Q4 2018 $0 -$2.91M -100% 31 Dec 2018 10-K 16 Mar 2020
Q3 2018 $5.96M 30 Sep 2018 10-Q 05 Nov 2018
Q2 2018 $4.88M 30 Jun 2018 10-Q 07 Aug 2018
Q4 2017 $2.91M 31 Dec 2017 10-K 15 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.